Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Singular Genomics Systems (OMIC)
NASDAQ:OMIC
RESEARCH TOOLSreports
Holding OMIC?
Track your performance easily
OMIC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.34 - $19.80
Previous Close$16.79
Volume237.17K
Average Volume (3M)87.29K
Market Cap
$41.90M
Enterprise Value-$19.51M
Total Cash (Recent Filing)$133.20M
Total Debt (Recent Filing)$71.79M
Price to Earnings (P/E)―
Beta2.90
Next Earnings
Nov 05, 2024EPS Estimate
-$8.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-37.37
Shares Outstanding2,495,694
10 Day Avg. Volume516,719
30 Day Avg. Volume87,293
Standard Deviation0.19
R-Squared0.13
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.29
Price to Sales (P/S)15.39
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-7.17
Enterprise Value/Gross Profit34.97
Enterprise Value/Ebitda0.24
Forecast
1Y Price Target
$6.50Price Target Upside-59.93% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Singular Genomics Systems News
Bulls Say, Bears Say
Bulls Say
Business Model ShiftThe strategic shift to a reagent rental model shows a promising change in revenue streams, potentially leading to more stable and recurring income over time.
Financial PerformanceThe operating loss was narrower than both Goldman Sachs and consensus estimates, indicating a more controlled expense management than the market anticipated.
Growth OutlookExpectations of accelerated placements and new product rollouts present a strong case for future revenue growth and market penetration.
Bears Say
Earnings ReportOMIC reported 3Q23 revenue of $462td which was below Visible Alpha Consensus Data/GSe of $1.3mn.
Guidance UpdateThe company did not update previous guidance of ~2-4 G4 instruments per month on average for 2023.
Sales PerformanceOMIC made progress in 3Q with 5 G4 placements but sales missed as customers shifted to more capex-light purchasing.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OMIC FAQ
What was Singular Genomics Systems’s price range in the past 12 months?
Singular Genomics Systems lowest stock price was $5.34 and its highest was $19.80 in the past 12 months.
What is Singular Genomics Systems’s market cap?
Currently, no data Available
When is Singular Genomics Systems’s upcoming earnings report date?
Singular Genomics Systems’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Singular Genomics Systems’s earnings last quarter?
Singular Genomics Systems released its earnings results on Aug 13, 2024. The company reported -$8.57 earnings per share for the quarter, beating the consensus estimate of -$8.86 by $0.29.
Is Singular Genomics Systems overvalued?
According to Wall Street analysts Singular Genomics Systems’s price is currently Overvalued.
Does Singular Genomics Systems pay dividends?
Singular Genomics Systems does not currently pay dividends.
What is Singular Genomics Systems’s EPS estimate?
Singular Genomics Systems’s EPS estimate is -$8.24.
How many shares outstanding does Singular Genomics Systems have?
Singular Genomics Systems has 2,495,694 shares outstanding.
What happened to Singular Genomics Systems’s price movement after its last earnings report?
Singular Genomics Systems reported an EPS of -$8.57 in its last earnings report, beating expectations of -$8.86. Following the earnings report the stock price went up 2.528%.
Which hedge fund is a major shareholder of Singular Genomics Systems?
Among the largest hedge funds holding Singular Genomics Systems’s share is Deerfield Management Company, LP. It holds Singular Genomics Systems’s shares valued at 1M.
---
Singular Genomics Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.50 (-59.93% Downside)
$6.50 (-59.93% Downside)
Blogger Sentiment
Bearish
OMIC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 76.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
42.04%
12-Months-Change
Fundamentals
Return on Equity
-51.61%
Trailing 12-Months
Asset Growth
-22.53%
Trailing 12-Months
Company Description
Singular Genomics Systems
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Integrated Solution is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
---
OMIC Earnings Call
Q2 2024
0:00 / 0:00
---
OMIC Stock 12 Month Forecast
Average Price Target
$6.50
▼(-59.93% Downside)
Technical Analysis
Best Analysts Covering OMIC
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+26.90%
reiterated a buy rating last month
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +26.90% per trade.
---